HCA Holdings, Inc. (HCA) Given Consensus Recommendation of “Buy” by Brokerages
Shares of HCA Holdings, Inc. (NYSE:HCA) have been assigned a consensus rating of “Buy” from the nineteen ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating on the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $92.60.
HCA has been the topic of a number of recent research reports. Robert W. Baird lowered their target price on HCA Holdings from $95.00 to $93.00 and set an “outperform” rating on the stock in a research note on Tuesday, August 22nd. ValuEngine downgraded HCA Holdings from a “buy” rating to a “hold” rating in a research report on Thursday. Argus initiated coverage on HCA Holdings in a research report on Wednesday, June 28th. They set a “buy” rating and a $100.00 price target on the stock. Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 price target on shares of HCA Holdings in a research report on Wednesday. Finally, Bank of America Corporation downgraded HCA Holdings from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $102.00 to $92.00 in a research report on Wednesday, July 26th.
TRADEMARK VIOLATION WARNING: This piece was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/09/hca-holdings-inc-hca-given-consensus-recommendation-of-buy-by-brokerages.html.
HCA Holdings (NYSE:HCA) traded up 0.89% on Friday, hitting $77.05. The stock had a trading volume of 1,922,216 shares. HCA Holdings has a 12 month low of $67.00 and a 12 month high of $91.03. The company’s 50 day moving average is $79.21 and its 200-day moving average is $83.78. The stock has a market cap of $27.83 billion, a P/E ratio of 10.33 and a beta of 0.67.
HCA Holdings (NYSE:HCA) last issued its earnings results on Tuesday, July 25th. The company reported $1.75 EPS for the quarter, missing analysts’ consensus estimates of $1.80 by $0.05. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The company had revenue of $10.73 billion during the quarter, compared to analysts’ expectations of $10.76 billion. During the same quarter in the previous year, the company earned $1.66 EPS. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. Analysts forecast that HCA Holdings will post $7.19 EPS for the current year.
In other news, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $79.88, for a total transaction of $171,742.00. Following the completion of the transaction, the insider now directly owns 12,363 shares in the company, valued at $987,556.44. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jonathan B. Perlin sold 71,063 shares of the firm’s stock in a transaction on Thursday, June 22nd. The stock was sold at an average price of $86.00, for a total value of $6,111,418.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 77,513 shares of company stock valued at $6,651,455. Company insiders own 2.90% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. Northwestern Mutual Wealth Management Co. boosted its holdings in HCA Holdings by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after purchasing an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. boosted its holdings in HCA Holdings by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after purchasing an additional 320 shares during the period. Atlantic Trust LLC purchased a new position in HCA Holdings in the second quarter valued at $118,000. Lee Financial Co purchased a new position in HCA Holdings in the second quarter valued at $125,000. Finally, Acrospire Investment Management LLC boosted its holdings in HCA Holdings by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after purchasing an additional 200 shares during the period. Hedge funds and other institutional investors own 73.77% of the company’s stock.
About HCA Holdings
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.